Order Article Reprints

Chen K-C, Chung C-H, Lu C-H, Tzeng N-S, Lee C-H, Su S-C, Kuo F-C, Liu J-S, Hsieh C-H, Chien W-C. Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan. Journal of Clinical Medicine. 2020; 9(3):660. https://doi.org/10.3390/jcm9030660

Chen, Kuan-Chan, Chi-Hsiang Chung, Chieh-Hua Lu, Nian-Sheng Tzeng, Chien-Hsing Lee, Sheng-Chiang Su, Feng-Chih Kuo, Jhih-Syuan Liu, Chang-Hsun Hsieh, and Wu-Chien Chien. 2020. "Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan" Journal of Clinical Medicine 9, no. 3: 660. https://doi.org/10.3390/jcm9030660

Chen, K. -C., Chung, C. -H., Lu, C. -H., Tzeng, N. -S., Lee, C. -H., Su, S. -C., Kuo, F. -C., Liu, J. -S., Hsieh, C. -H., & Chien, W. -C. (2020). Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan. Journal of Clinical Medicine, 9(3), 660. https://doi.org/10.3390/jcm9030660